Linus Tan

Associate at Vivo Capital

Linus Tan, Ph.D., joined Vivo with a fundamental and translational research background in biomedical field. Prior to Vivo, Linus worked for China Asset Management Co., Ltd. as a senior associate focusing on Biotech, Vaccine & CRO industries. He also served as research assistant for Novo Nordisk A/S in discovery and optimization of next-generation peptide drug candidates.

Linus has conducted research in peptide drug discovery and ubiquitin signaling pathway and published his research in multiple peer-reviewed journals, including JACS, ChemComm and CCL, etc. Linus received his B.S. in Organic Chemistry from University of Science & Technology of China and Ph.D. in Chemical Biology from Tsinghua University.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Vivo Capital

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $4.3 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia.


Employees

51-200

Links